Elisabeth Buchdunger Selected Research

Elisabeth Buchdunger Research Topics

Disease

9	Neoplasms (Cancer) 12/2014 - 01/2002
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2008 - 01/2002
5	Leukemia 04/2005 - 02/2002
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2005 - 09/2002
2	Philadelphia Chromosome 05/2004 - 01/2002
2	Blast Crisis (Blast Phase) 05/2004 - 08/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2004 - 01/2002
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2002 - 01/2002
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 09/2002 - 01/2002
1	Leiomyosarcoma 12/2014
1	Fibrosis (Cirrhosis) 07/2008
1	Myocarditis (Carditis) 07/2008
1	Disease Progression 04/2005
1	Breast Neoplasms (Breast Cancer) 04/2004
1	Hyperplasia 03/2004
1	Neointima 03/2004
1	Body Weight (Weight, Body) 09/2003
1	Anaplastic Thyroid Carcinoma 09/2003
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2003
1	Arteriosclerosis 02/2003
1	Hypertension (High Blood Pressure) 10/2002
1	Neoplasm Metastasis (Metastasis) 09/2002
1	Dermatofibrosarcoma 09/2002
1	Glioblastoma (Glioblastoma Multiforme) 09/2002
1	Carcinoma (Carcinomatosis) 09/2002
1	Genetic Translocation (Chromosomal Translocation) 01/2002

Drug/Important Bio-Agent (IBA)

14	Imatinib Mesylate (Gleevec)FDA Link 12/2008 - 01/2002
7	Phosphotransferases (Kinase)IBA 12/2014 - 02/2002
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2014 - 01/2002
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2008 - 01/2002
4	Platelet-Derived Growth FactorIBA 07/2008 - 10/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014 - 12/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 09/2002
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2014 - 02/2002
3	Pharmaceutical PreparationsIBA 04/2004 - 12/2002
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2014 - 02/2002
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2005 - 05/2004
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2005 - 05/2004
2	NVP ADW742IBA 02/2005 - 05/2004
2	src-Family KinasesIBA 05/2004 - 01/2003
2	Protein Kinases (Protein Kinase)IBA 09/2002 - 02/2002
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2014
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	Becaplermin (PDGF-BB)FDA Link 12/2014
1	vatalanib (PTK787)IBA 12/2014
1	Tyrosine (L-Tyrosine)FDA Link 12/2014
1	nilotinib FDA Link 12/2008
1	Dasatinib (BMS 354825)FDA Link 12/2008
1	Protein Kinase InhibitorsIBA 12/2008
1	platelet-derived growth factor AIBA 07/2008
1	Hydroxyproline (4 Hydroxyproline)IBA 07/2008
1	Messenger RNA (mRNA)IBA 04/2005
1	CGP 76030IBA 05/2004
1	Stem Cell FactorIBA 05/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2004
1	anilinoquinazolineIBA 04/2004
1	CamptothecinIBA 04/2004
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2004
1	LigandsIBA 03/2004
1	Vascular Endothelial Growth Factor CIBA 03/2004
1	epothilone B (EPO906)IBA 09/2003
1	CytokinesIBA 02/2003
1	CholesterolIBA 02/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2002
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2002
1	Therapeutic UsesIBA 10/2002
1	Fluorouracil (Carac)FDA LinkGeneric 10/2002
1	bcr-abl Fusion ProteinsIBA 09/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2002
1	Tyrosine Kinase InhibitorsIBA 07/2002
1	PKI 166IBA 02/2002
1	tyrosine receptor (receptor, tyrosine)IBA 02/2002
1	ErbB Receptors (EGF Receptor)IBA 02/2002
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 12/2014 - 02/2002
5	Therapeutics 12/2014 - 01/2002